Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,542,305
  • Shares Outstanding, K 129,388
  • Annual Sales, $ 660,570 K
  • Annual Income, $ -78,730 K
  • EBIT $ -121 M
  • EBITDA $ -45 M
  • 60-Month Beta 1.59
  • Price/Sales 2.32
  • Price/Cash Flow 27.01
  • Price/Book 1.83

Options Overview Details

View History
  • Implied Volatility 61.28% (-7.12%)
  • Historical Volatility 40.91%
  • IV Percentile 33%
  • IV Rank 23.33%
  • IV High 153.46% on 12/04/25
  • IV Low 33.23% on 01/08/25
  • Expected Move (DTE 3) 1.04 (8.87%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 18
  • Volume Avg (30-Day) 435
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 28,844
  • Open Int (30-Day) 29,329
  • Expected Range 10.65 to 12.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.05
  • Number of Estimates 4
  • High Estimate -0.03
  • Low Estimate -0.07
  • Prior Year -0.02
  • Growth Rate Est. (year over year) -150.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.89 +17.85%
on 11/18/25
12.51 -6.80%
on 11/25/25
+1.31 (+12.72%)
since 11/14/25
3-Month
7.56 +54.17%
on 09/30/25
12.51 -6.80%
on 11/25/25
+3.66 (+45.87%)
since 09/16/25
52-Week
4.72 +146.93%
on 08/01/25
19.11 -39.03%
on 01/08/25
-6.31 (-35.14%)
since 12/16/24

Most Recent Stories

More News
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation

NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026

NEO : 11.65 (-2.27%)
NeoGenomics to Present New ctDNA Research at SABCS 2025

Data include findings generated using the RaDaR 1.0 assay to assess molecular residual disease and recurrence risk in early breast cancer

NEO : 11.65 (-2.27%)
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will present new data demonstrating how comprehensive genomic profiling (CGP) can refine...

NEO : 11.65 (-2.27%)
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

NEO : 11.65 (-2.27%)
3 Overrated Stocks That Concern Us

3 Overrated Stocks That Concern Us

MOV : 21.82 (+0.51%)
EXAS : 101.67 (-0.07%)
NEO : 11.65 (-2.27%)
1 Cash-Burning Stock to Research Further and 2 We Brush Off

1 Cash-Burning Stock to Research Further and 2 We Brush Off

LEN : 118.02 (-1.43%)
NEO : 11.65 (-2.27%)
SMRT : 2.05 (-0.24%)
NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know

NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know

FTRE : 16.18 (+0.75%)
ACHC : 14.53 (+2.18%)
NEO : 11.65 (-2.27%)
1 High-Flying Stock on Our Buy List and 2 We Find Risky

1 High-Flying Stock on Our Buy List and 2 We Find Risky

APP : 666.28 (-1.32%)
NEO : 11.65 (-2.27%)
WMT : 116.17 (-0.53%)
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off

1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off

CROX : 90.78 (+0.13%)
NEO : 11.65 (-2.27%)
HOMB : 28.70 (-0.17%)
3 Volatile Stocks We Keep Off Our Radar

3 Volatile Stocks We Keep Off Our Radar

COUR : 7.94 (+1.15%)
NEO : 11.65 (-2.27%)
DAY : 69.25 (-0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 12.56
2nd Resistance Point 12.37
1st Resistance Point 12.15
Last Price 11.65
1st Support Level 11.73
2nd Support Level 11.54
3rd Support Level 11.32

See More

52-Week High 19.11
Fibonacci 61.8% 13.62
Fibonacci 50% 11.92
Last Price 11.65
Fibonacci 38.2% 10.22
52-Week Low 4.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar